Ceruloplasmin (CP) is a 132 kd cuproprotein which, together with transferri
n, provides the majority of anti-oxidant capacity in serum. Increased iron
deposition and lipid peroxidation in the basal ganglia of subjects with her
editary CP deficiency suggest that CP may serve as an anti-oxidant in the b
rain as well. The present study compared CP immunoreactivity in brain speci
mens from normal controls and subjects with neurodegenerative disorders (Al
zheimer's disease [AD], Parkinson's disease [PD], progressive supranuclear
palsy [PSP], and Huntington's disease [HD]) (n = 5 per group). The relative
intensity of neuronal CP staining and the numbers of CP-stained neurons pe
r 25x microscope field were determined in hippocampus (CAI, subiculum, and
parahippocampal gyrus), parietal cortex, frontal cortex, substantia nigra,
and caudate. CP was detected in both neurons and astrocytes in all specimen
s, and in senile plaques and occasional neurofibrillary tangles in AD brain
. Neuronal CP staining intensity tended to increase in most AD brain region
s, but was statistically significant vs controls only in the CAI region of
hippocampus (p = .016). Neuronal CP staining in brain specimens from other
neurodegenerative disorders showed a slight but nonsignificant increase vs
controls. The numbers of CP-stained neurons per field did not differ betwee
n the various neurodegenerative disorders and controls. These results sugge
st that a modest increase in neuronal CP content is present in the AD brain
, and lesser elevations in neuronal CP occur in the other neurodegenerative
disorders in this study. Though CP functions as both an acute phase protei
n and an anti-oxidant in peripheral tissues, whether it does so in the brai
n remains to be determined.